Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis
This study was performed to reveal the risk factors associated with mortality in people living with HIV (PLHIV) who were diagnosed with COVID-19. Studies reporting deaths among PLHIV and infected with SARS-CoV-2 were investigated. After protocol setup and registration, the extracted sources were categorized and assessed for quality. This study examined ten articles with a total of 46,136 patients. Patients aged ≥ 60 years (hazard ratio [HR] = 2.22; 95% CI: 1.617, 3.050; p < 0.001), male (HR = 1.668; 95% CI: 1.179, 2.361; p = 0.004), and people with diabetes (risk ratio [RR] = 3.34; 95% CI: 1.45, 7.68; p = 0.005) were ...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Mahmoud Kandeel Source Type: research
HIV infection and esophageal cancer in Sub-Saharan Africa: a comprehensive meta-analysis
This study conducted an exhaustive computerized search of databases, including Medline/PubMed, Embase, Web of Science, Scopus, Cochrane library, and African Journals Online, to identify eligible studies up to October 2023. HIV infection was the exposure, esophageal cancer risk was the outcome, and healthy subjects with no cancer history served as comparators. Study quality was assessed using the Newcastle-Ottawa scale, and potential publication bias was evaluated through funnel plots and the Egger test. Meta-analyses were conducted using Stata 17.0 software and involved a thorough examination of 98,397 studies. Out of thes...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Gabriel Kamsu-Tchuente Eugene J Ndebia Source Type: research
HTLV in Sweden
AIDS Rev. 2024;26(1):41-47. doi: 10.24875/AIDSRev.24000002.ABSTRACTSweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV) infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk groups such as HTLV-2 among intravenous drug users (IVDU) and people originating from HTLV-1 highly endemic areas. Thus, in the most recent study from 2012, the prevalence of HTLV-2 among IVDU in Stockholm was 3.2%. However, much of the epidemiological data on HTLV in Sweden stems from studies conducted primarily between the 1990s and 2007, and the impact of migration to Sweden dur...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Jan Vesterbacka Anna-Karin Svensson Piotr Nowak Source Type: research
HIV/HBV coinfection: understanding the complex interactions and their impact on spontaneous HBV clearance, chronic liver damage, cirrhosis, and hepatocellular carcinoma
AIDS Rev. 2024;26(1):32-40. doi: 10.24875/AIDSRev.23000019.ABSTRACTCompared to either HIV or hepatitis B virus (HBV) monoinfected individuals, HIV/HBV-coinfected individuals have a decreased probability of spontaneous HBV clearance and a greater risk of developing chronic liver damage and a faster progression to cirrhosis and hepatocellular carcinoma. This manuscript attempts to provide a comprehensive review of the landscape of current HIV/HBV coinfection research with a focus on the intricate interactions between these two viruses. Our review will help understand the disease dynamics of HIV/HBV coinfection and has import...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Jingwen Xiao Yongzheng Zhang Jia Wu Xinping -Chen Wei Zou Source Type: research
Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis
This study was performed to reveal the risk factors associated with mortality in people living with HIV (PLHIV) who were diagnosed with COVID-19. Studies reporting deaths among PLHIV and infected with SARS-CoV-2 were investigated. After protocol setup and registration, the extracted sources were categorized and assessed for quality. This study examined ten articles with a total of 46,136 patients. Patients aged ≥ 60 years (hazard ratio [HR] = 2.22; 95% CI: 1.617, 3.050; p < 0.001), male (HR = 1.668; 95% CI: 1.179, 2.361; p = 0.004), and people with diabetes (risk ratio [RR] = 3.34; 95% CI: 1.45, 7.68; p = 0.005) were ...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Mahmoud Kandeel Source Type: research
HIV infection and esophageal cancer in Sub-Saharan Africa: a comprehensive meta-analysis
This study conducted an exhaustive computerized search of databases, including Medline/PubMed, Embase, Web of Science, Scopus, Cochrane library, and African Journals Online, to identify eligible studies up to October 2023. HIV infection was the exposure, esophageal cancer risk was the outcome, and healthy subjects with no cancer history served as comparators. Study quality was assessed using the Newcastle-Ottawa scale, and potential publication bias was evaluated through funnel plots and the Egger test. Meta-analyses were conducted using Stata 17.0 software and involved a thorough examination of 98,397 studies. Out of thes...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Gabriel Kamsu-Tchuente Eugene J Ndebia Source Type: research
HTLV in Sweden
AIDS Rev. 2024;26(1):41-47. doi: 10.24875/AIDSRev.24000002.ABSTRACTSweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV) infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk groups such as HTLV-2 among intravenous drug users (IVDU) and people originating from HTLV-1 highly endemic areas. Thus, in the most recent study from 2012, the prevalence of HTLV-2 among IVDU in Stockholm was 3.2%. However, much of the epidemiological data on HTLV in Sweden stems from studies conducted primarily between the 1990s and 2007, and the impact of migration to Sweden dur...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Jan Vesterbacka Anna-Karin Svensson Piotr Nowak Source Type: research
HIV/HBV coinfection: understanding the complex interactions and their impact on spontaneous HBV clearance, chronic liver damage, cirrhosis, and hepatocellular carcinoma
AIDS Rev. 2024;26(1):32-40. doi: 10.24875/AIDSRev.23000019.ABSTRACTCompared to either HIV or hepatitis B virus (HBV) monoinfected individuals, HIV/HBV-coinfected individuals have a decreased probability of spontaneous HBV clearance and a greater risk of developing chronic liver damage and a faster progression to cirrhosis and hepatocellular carcinoma. This manuscript attempts to provide a comprehensive review of the landscape of current HIV/HBV coinfection research with a focus on the intricate interactions between these two viruses. Our review will help understand the disease dynamics of HIV/HBV coinfection and has import...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Jingwen Xiao Yongzheng Zhang Jia Wu Xinping -Chen Wei Zou Source Type: research
Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis
This study was performed to reveal the risk factors associated with mortality in people living with HIV (PLHIV) who were diagnosed with COVID-19. Studies reporting deaths among PLHIV and infected with SARS-CoV-2 were investigated. After protocol setup and registration, the extracted sources were categorized and assessed for quality. This study examined ten articles with a total of 46,136 patients. Patients aged ≥ 60 years (hazard ratio [HR] = 2.22; 95% CI: 1.617, 3.050; p < 0.001), male (HR = 1.668; 95% CI: 1.179, 2.361; p = 0.004), and people with diabetes (risk ratio [RR] = 3.34; 95% CI: 1.45, 7.68; p = 0.005) were ...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Mahmoud Kandeel Source Type: research
HIV infection and esophageal cancer in Sub-Saharan Africa: a comprehensive meta-analysis
This study conducted an exhaustive computerized search of databases, including Medline/PubMed, Embase, Web of Science, Scopus, Cochrane library, and African Journals Online, to identify eligible studies up to October 2023. HIV infection was the exposure, esophageal cancer risk was the outcome, and healthy subjects with no cancer history served as comparators. Study quality was assessed using the Newcastle-Ottawa scale, and potential publication bias was evaluated through funnel plots and the Egger test. Meta-analyses were conducted using Stata 17.0 software and involved a thorough examination of 98,397 studies. Out of thes...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Gabriel Kamsu-Tchuente Eugene J Ndebia Source Type: research
HTLV in Sweden
AIDS Rev. 2024;26(1):41-47. doi: 10.24875/AIDSRev.24000002.ABSTRACTSweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV) infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk groups such as HTLV-2 among intravenous drug users (IVDU) and people originating from HTLV-1 highly endemic areas. Thus, in the most recent study from 2012, the prevalence of HTLV-2 among IVDU in Stockholm was 3.2%. However, much of the epidemiological data on HTLV in Sweden stems from studies conducted primarily between the 1990s and 2007, and the impact of migration to Sweden dur...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Jan Vesterbacka Anna-Karin Svensson Piotr Nowak Source Type: research
HIV/HBV coinfection: understanding the complex interactions and their impact on spontaneous HBV clearance, chronic liver damage, cirrhosis, and hepatocellular carcinoma
AIDS Rev. 2024;26(1):32-40. doi: 10.24875/AIDSRev.23000019.ABSTRACTCompared to either HIV or hepatitis B virus (HBV) monoinfected individuals, HIV/HBV-coinfected individuals have a decreased probability of spontaneous HBV clearance and a greater risk of developing chronic liver damage and a faster progression to cirrhosis and hepatocellular carcinoma. This manuscript attempts to provide a comprehensive review of the landscape of current HIV/HBV coinfection research with a focus on the intricate interactions between these two viruses. Our review will help understand the disease dynamics of HIV/HBV coinfection and has import...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Jingwen Xiao Yongzheng Zhang Jia Wu Xinping -Chen Wei Zou Source Type: research
Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis
This study was performed to reveal the risk factors associated with mortality in people living with HIV (PLHIV) who were diagnosed with COVID-19. Studies reporting deaths among PLHIV and infected with SARS-CoV-2 were investigated. After protocol setup and registration, the extracted sources were categorized and assessed for quality. This study examined ten articles with a total of 46,136 patients. Patients aged ≥ 60 years (hazard ratio [HR] = 2.22; 95% CI: 1.617, 3.050; p < 0.001), male (HR = 1.668; 95% CI: 1.179, 2.361; p = 0.004), and people with diabetes (risk ratio [RR] = 3.34; 95% CI: 1.45, 7.68; p = 0.005) were ...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Mahmoud Kandeel Source Type: research
HIV infection and esophageal cancer in Sub-Saharan Africa: a comprehensive meta-analysis
This study conducted an exhaustive computerized search of databases, including Medline/PubMed, Embase, Web of Science, Scopus, Cochrane library, and African Journals Online, to identify eligible studies up to October 2023. HIV infection was the exposure, esophageal cancer risk was the outcome, and healthy subjects with no cancer history served as comparators. Study quality was assessed using the Newcastle-Ottawa scale, and potential publication bias was evaluated through funnel plots and the Egger test. Meta-analyses were conducted using Stata 17.0 software and involved a thorough examination of 98,397 studies. Out of thes...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Gabriel Kamsu-Tchuente Eugene J Ndebia Source Type: research
HTLV in Sweden
AIDS Rev. 2024;26(1):41-47. doi: 10.24875/AIDSRev.24000002.ABSTRACTSweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV) infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk groups such as HTLV-2 among intravenous drug users (IVDU) and people originating from HTLV-1 highly endemic areas. Thus, in the most recent study from 2012, the prevalence of HTLV-2 among IVDU in Stockholm was 3.2%. However, much of the epidemiological data on HTLV in Sweden stems from studies conducted primarily between the 1990s and 2007, and the impact of migration to Sweden dur...
Source: AIDS Reviews - March 26, 2024 Category: Infectious Diseases Authors: Jan Vesterbacka Anna-Karin Svensson Piotr Nowak Source Type: research
